Select Your Language

24/7 Live Chat Call Us

Upcoming Changes to FDA Electronic Medical Device Reporting (eMDR) in 2018

Medical device manufacturers and importers are required to report “adverse events” to FDA when their device has caused or contributed to death or serious injury.  An “adverse event” is when a device has a malfunction that could cause death or serious injury.  Importers report this information to the manufacturer.  The U.S. Food and Drug Administration (FDA) has announced that it will update certain codes used for Adverse Event Reporting through the Electronic Medical Device Reporting (eMDR) system on April 6, 2018.

The Agency will replace the codes for FDA Device Problem, Manufacturer Evaluation Method, Manufacturer Evaluation Result, and Manufacturer Evaluation Conclusion with similar codes established by the International Medical Device Regulators Forum (IMDRF).

IMDRF has released public references to help map FDA codes to the new codes during the interim before the update.  For example, the current FDA Device Problem Code 2682 refers to an “issue associated with the interaction between the patient’s physiology or anatomy and the device that affects patient and/or device.” This code corresponds to and will be replaced by IMDRF code A0101, a “problem associated with the interaction between the patient’s physiology or anatomy and the device that affects the patient and/or the device.”

Despite this mapping, reporting parties will not be able to rely on FDA codes after the update.  Some IMDRF codes do not have a current FDA equivalent, and FDA has further stated that the submission of retired FDA codes following the update will be rejected by the eMDR system.   As such, reporting parties should familiarize themselves with the IMDRF codes for a smooth transition into these changes.

If you are a reporting party in need of assistance, Registrar Corp can guide you through the eSubmitter software and facilitate your Adverse Event Report submission to eMDR.  Registrar Corp offers Adverse Event Reporting assistance at no fee to clients of our U.S. Agent Service.  Call us at +1-757-224-0177.  Alternatively, you can chat with a Regulatory Advisor 24 hours a day at www.registrarcorp.com/livehelp.